Pleomorphic adenoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Pleomorphic adenoma}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR Effective measures for..." |
|||
| (13 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pleomorphic adenoma}} | {{Pleomorphic adenoma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{M.N}} | ||
==Overview== | ==Overview== | ||
Effective measures for the [[secondary prevention]] of pleomorphic adenoma include timely [[physical examination]], [[Radiological|radiologic]] [[imaging]], [[blood tests]]. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
*Secondary preventive measures include timely [[screening]] at regular intervals with routine [[physical examination]], [[radiological]] [[imaging]], and [[blood tests]]. | |||
*Once diagnosed and successfully treated, [[patients]] with pleomorphic adenoma are followed-up every 6 or 12 months. | |||
*[ | |||
==References== | ==References== | ||
| Line 25: | Line 15: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | |||
[[Category: Otolaryngology]] | |||
[[Category: Medicine]] | |||
[[Category: Oncology]] | |||
[[Category: Surgery]] | |||
[[Category: Up-To-Date]] | |||
Latest revision as of 20:30, 28 January 2019
|
Pleomorphic adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pleomorphic adenoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Pleomorphic adenoma secondary prevention |
|
Risk calculators and risk factors for Pleomorphic adenoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]
Overview
Effective measures for the secondary prevention of pleomorphic adenoma include timely physical examination, radiologic imaging, blood tests.
Secondary Prevention
- Secondary preventive measures include timely screening at regular intervals with routine physical examination, radiological imaging, and blood tests.
- Once diagnosed and successfully treated, patients with pleomorphic adenoma are followed-up every 6 or 12 months.